Portable Medical Devices Market Report 2025

The portable medical devices market size has grown rapidly in recent years. It will grow from $55.17 billion in 2024 to $61.25 billion in 2025 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to miniaturization of electronics, increasing chronic diseases, aging population, telehealth and remote monitoring, point-of-care testing.

The portable medical devices market size is expected to see rapid growth in the next few years. It will grow to $95.56 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to global health pandemics, digital health integration, increased home healthcare, healthcare cost containment, and wearable health tech adoption. Major trends in the forecast period include advancements in battery technology, AI and machine learning integration, smart inhalers and drug delivery devices, integration of augmented reality, and blockchain technology in healthcare.

The anticipated increase in the prevalence of chronic diseases is set to drive the growth of the portable medical devices market in the coming years. Chronic diseases, defined as conditions persisting for a year or longer, requiring ongoing medical treatment and impacting daily activities, can be managed with the assistance of portable medical devices. These devices aid patients in tracking health-related conditions, particularly in post-acute, rehabilitation, and chronic cases. For example, the National Library of Medicine reported in January 2023 that the number of people aged 50 and older in the US with at least one chronic condition is projected to rise by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050, thereby driving the growth of the portable medical devices market.

The demand for advanced wearable devices is expected to further propel the portable medical devices market. Advanced wearable devices, electronic devices worn on the body that communicate with other devices to transmit or collect data, are transforming the market by providing real-time health monitoring, improved data accuracy, and increased patient engagement. Vicert reported in November 2022 that 533.6 million wearable devices were shipped in 2021, including watches, hearing aids, and other assistive devices. The wearables or earwear category is forecasted to grow to 105 million devices by 2023, contributing to the growth of the portable medical devices market.

Technological innovation is a prominent trend in the portable medical devices market, with major companies incorporating new technologies to maintain their market standing. In November 2022, Philips, a Netherlands-based conglomerate corporation, introduced the Compact 5000 series, a next-generation compact portable ultrasound solution. This system features Philips collaboration live secure real-time telemedicine software, facilitating communication for additional clinical expertise through voice, text, screen sharing, and video streaming. The Ultrasound Compact 5000 Series system, designed with an optional battery for 2.5 hours of scanning time and 20% faster power-up capabilities, aims to enhance accessibility to high-end cart-based ultrasound machines' diagnostic capabilities.

Major companies in the portable medical devices market are prioritizing product innovation, particularly through telemedicine solutions to enhance remote patient monitoring and improve access to quality healthcare in various settings. A telemedicine solution is a technology-based platform that allows healthcare providers to deliver medical care remotely via digital communication tools, such as video consultations and remote monitoring devices. For example, in January 2024, Rudolf Riester GmbH, a Germany-based manufacturer of medical devices for primary, hospital, and specialist care, introduced a comprehensive telemedicine solution designed to integrate various medical devices for smooth remote consultations and patient monitoring. This innovative platform features the ri-sonic E-stethoscope combined with eMurmur AI for detecting heart murmurs, thereby improving the quality and accessibility of healthcare, especially in remote areas.

In June 2023, Arterex, an Italy-based medical device company, acquired NextPhase Medical Devices LLC for an undisclosed sum. This acquisition aims to enhance Arterex's capabilities within the medical device sector, particularly in developing advanced technologies for surgical applications. The integration of NextPhase's expertise is expected to strengthen Arterex's product offerings and accelerate its growth in the market. NextPhase Medical Devices LLC is a US-based manufacturer of portable and single-use medical devices.

Major companies operating in the portable medical devices market include Cardinal Health Inc., Johnson & Johnson Services Inc., Panasonic Holdings Corporation, Abbott Laboratories, Medtronic PLC, Siemens Healthcare Private Limited, Fujifilm Holdings Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Biotricity Inc., Grifols S.A, Terumo Corporation, Fresenius Kabi AG, GE HealthCare Technologies Inc., Hologic Inc., Dexcom Inc., QIAGEN GmbH, Nipro Corporation, Omnivision Technologies Inc., Shockwave Medical Inc., SARSTEDT GROUP, Morepen Laboratories Ltd., Omron Healthcare Inc., Natus Medical Incorporated, Samsung Healthcare, Pulsatom Health Care Pvt. Ltd.

North America was the largest region in the portable medical devices market in 2024. The regions covered in the portable medical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the portable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Portable medical devices encompass any device designed for standalone or combined use with the purpose of medical intervention. This category includes instruments, equipment, implements, machines, appliances, implants, reagents for in vitro use, software, materials, or similar items that are easily transportable.

The primary types of portable medical devices include therapeutics, smart wearable medical devices, diagnostic imaging, monitoring devices, neuromonitoring, cardiac monitoring, respiratory monitoring, neonatal monitoring, fetal monitoring, and others. Therapeutics pertains to the branch of medicine focused on treating and caring for patients to prevent and treat diseases, as well as alleviate suffering from pain or injury. Various applications span cardiology, orthopedics, gynecology, urology, gastrointestinal, neurology, and others. These devices find application across diverse end-users, including hospitals, clinics, homecare patients, ambulatory care centers, surgical centers, and others.

The portable medical devices market research report is one of a series of new reports that provides portable medical devices market statistics, including portable medical devices industry global market size, regional shares, competitors with a portable medical devices market share, detailed portable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the portable medical devices industry. This portable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The portable medical devices market consists of sales of portable devices including spirometers, pulse oximeters, nebulizers, and blood pressure monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.